The Board has determined that discontinuance of the 100 percent rating for B-cell lymphoma was proper, and separate non-compensable ratings for peripheral neuropathy of each upper and lower extremity are also appropriate.
The deciding factor: The Veteran's B-cell lymphoma is no longer active following completion of chemotherapy in February 2007. The RO appropriately reduced the rating to 10 percent effective April 1, 2008, based on the absence of active disease and discontinuance of treatment.
- Claimed conditions
- B-cell lymphoma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- July 29, 2014
- Citation
- 1433820
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 1433820.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's service connection claims for B-cell lymphoma, left and right lower extremity small fiber sensory neuropathy, and left hip fracture residuals are granted. The TDIU claim is also remanded.
- Whole decision: Remanded (sent back)
The Board has remanded the case due to an inadequate medical opinion regarding the Veteran's B-cell lymphoma and its recurrence or metastasis at the time of the reduction in rating.
- Whole decision: Remanded (sent back)
The Veteran's B-cell lymphoma is being remanded for further investigation and an addendum opinion to consider potential toxic exposures during service, including JP-5, diesel fuel, and firefighting foam.
- Whole decision: Dismissed
The Board dismissed the veteran's appeals for service connection for bilateral hearing loss, tinnitus, cervical strain, esophagus stricture, traumatic brain injury (TBI), and migraine headaches due to untimely notice of disagreement. The appeal for B-cell lymphoma was remanded for further development.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.